2001
DOI: 10.1016/s0168-8278(00)00026-x
|View full text |Cite
|
Sign up to set email alerts
|

The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

12
189
4
1

Year Published

2002
2002
2010
2010

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 192 publications
(206 citation statements)
references
References 26 publications
12
189
4
1
Order By: Relevance
“…Although HCV may diminish HRQOL through complications of advanced cirrhosis, it may also diminish HRQOL in the absence of clinically significant liver disease. [8][9][10][11][12][13][14][15][16][17][18][19][20] The mechanism of HRQOL decrement in the absence of liver damage is unclear. Potential mechanisms include the development of extrahepatic somatic symptoms (e.g., HCVrelated arthralgia and myalgia), extrahepatic disorders (e.g., HCV-related cryoglobulinemia, sicca syndrome, glomerulonephritis), or HCV-related subclinical cognitive dysfunction, among others.…”
Section: Results Stratified By Clinical Anchorsmentioning
confidence: 99%
See 1 more Smart Citation
“…Although HCV may diminish HRQOL through complications of advanced cirrhosis, it may also diminish HRQOL in the absence of clinically significant liver disease. [8][9][10][11][12][13][14][15][16][17][18][19][20] The mechanism of HRQOL decrement in the absence of liver damage is unclear. Potential mechanisms include the development of extrahepatic somatic symptoms (e.g., HCVrelated arthralgia and myalgia), extrahepatic disorders (e.g., HCV-related cryoglobulinemia, sicca syndrome, glomerulonephritis), or HCV-related subclinical cognitive dysfunction, among others.…”
Section: Results Stratified By Clinical Anchorsmentioning
confidence: 99%
“…[4][5][6] However, these end-stage complications are relatively rare compared with the vast majority of patients with HCV in the absence of clinically significant liver disease. Despite the previous consensus that this majority of patients has asymptomatic seropositivity, 7 evolving data now indicate that HCV itself may diminish HRQOL in the absence of advanced liver disease, [8][9][10][11][12][13][14][15][16][17][18][19][20] perhaps as a result of extrahepatic symptoms related to HCV, cognitive dysfunction related to HCV, or a negative synergy between HCV and comorbid psychosocial disorders. 10,21 As awareness grows of the HRQOL decrement from HCV and its clinical consequences, investigators have be-come progressively interested in measuring HRQOL in HCV clinical trials.…”
mentioning
confidence: 99%
“…In contrast, scores of nonresponders decreased in 8 of 12 measures; the decrease in general health was significant (P Ͻ 0.05). 8 McHutchison et al 27 reported similar results in an evaluation of the effect of CHC and antiviral therapy on HRQL in 905 patients. At baseline, patients had significantly lower scores in 5 of 8 SF-36 domains compared with population norms.…”
mentioning
confidence: 77%
“…15 Table 2 lists 15 studies that compared HRQL between patients with HCV infection and healthy controls. 9,[15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32] Extrahepatic Manifestations of CHC Affecting HRQL Fatigue. Fatigue is among the most frequent and disabling extrahepatic features of CHC.…”
mentioning
confidence: 99%
See 1 more Smart Citation